Aquestive Therapeutics, Inc. (AQST)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.68−$0.1400 (−2.90%) on the dayAs of the close; data may be delayed.
AQST price, last 12 months
Key stats
- Previous close
- $4.82
- Open
- $4.82
- Day range
- $4.66 – $4.86
- 52-week range
- $2.93 – $7.55
- Volume
- 1.9M
- Avg volume (20 days)
- 2.3M
- Market cap
- $587.4M
Performance
1W+1.5%
1M−13.2%
3M+6.6%
6M+13.0%
YTD−27.6%
1Y−13.7%
vs S&P 500, 1Y−30.4 pts
Technicals and fundamentals
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $587.4M